Grant: Project Grant
Centre for Addiction and Mental Health (Toronto)
$1,181,924.00
Novel markers of risk for age-related neurodegeneration, senescence, and cognitive decline in adults with substance use disorders
EF 2024-25
Résumé
People living with substance use disorders (SUDs) have higher risk of developing dementia later in life. However, the mechanisms behind this link are poorly understood. Preliminary evidence suggests that substance use may make the body and brain age faster. A small brain region located near the base of the brain, called the midbrain, is involved in thinking abilities and may be particularly vulnerable to the effects of age and the effects of substance use. It is therefore possible that the health of this structure may partially explain the link between substance use and elevated risk for dementia. Since the midbrain is very well-characterized on the cellular and molecular level, demonstrating these links may allow us to develop more effective and personalized treatment and prevention strategies to reduce the risk of dementia and cognitive impairment in people with SUDs. To evaluate this hypothesis, we propose to study the association between aging across young and middle age (ages 18-60) and the health of the midbrain assessed through a brain imaging technique called neuromelanin-sensitive MRI in a large sample of people with SUDs and a comparison group without SUDs. In the same people, we will also assess the links among age, midbrain health, thinking abilities and blood measures associated with cell aging. We expect that people with SUDs will have signs of faster aging and will resemble older individuals without SUDs on measures of midbrain health. We also expect to identify which specific aspects of thinking abilities and cell aging may be most strongly related to midbrain health in those with SUDs. This may in turn direct us to developing specific interventions to help more effectively prevent cognitive decline in those with SUDs.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
509089
Name
Nikolova Yuliya S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Behavioural Sciences - B: Clinical Behavioural Sciences
Projecttitle
Novel markers of risk for age-related neurodegeneration, senescence, and cognitive decline in adults with substance use disorders
Programtype2
Operating Grants
Orgnameinp2
Centre for Addiction and Mental Health (Toronto)
Cihramount2
$1,181,924
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Aging; Biomarkers; Mri; Substance Use
Abstract
People living with substance use disorders (SUDs) have higher risk of developing dementia later in life. However, the mechanisms behind this link are poorly understood. Preliminary evidence suggests that substance use may make the body and brain age faster. A small brain region located near the base of the brain, called the midbrain, is involved in thinking abilities and may be particularly vulnerable to the effects of age and the effects of substance use. It is therefore possible that the health of this structure may partially explain the link between substance use and elevated risk for dementia. Since the midbrain is very well-characterized on the cellular and molecular level, demonstrating these links may allow us to develop more effective and personalized treatment and prevention strategies to reduce the risk of dementia and cognitive impairment in people with SUDs. To evaluate this hypothesis, we propose to study the association between aging across young and middle age (ages 18-60) and the health of the midbrain assessed through a brain imaging technique called neuromelanin-sensitive MRI in a large sample of people with SUDs and a comparison group without SUDs. In the same people, we will also assess the links among age, midbrain health, thinking abilities and blood measures associated with cell aging. We expect that people with SUDs will have signs of faster aging and will resemble older individuals without SUDs on measures of midbrain health. We also expect to identify which specific aspects of thinking abilities and cell aging may be most strongly related to midbrain health in those with SUDs. This may in turn direct us to developing specific interventions to help more effectively prevent cognitive decline in those with SUDs.
Competitiondate
202409
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Nikolova, Yuliya S; Quilty, Lena C; Vieira, Erica L
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $1,181,924~ $0~